Cargando…

HIGH-DOSE INSULIN EUGLYCEMIC THERAPY

Calcium channel blockers and beta-blockers toxicity/poisoning are one of the most common causes of poisoning. More importantly, they are among the deadliest types of poisoning caused by cardiac drugs that emergency physicians can encounter. Common toxidrome caused by these medications includes the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamzić, Jasmin, Raos, Dora, Radulović, Bojana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536162/
https://www.ncbi.nlm.nih.gov/pubmed/36304811
http://dx.doi.org/10.20471/acc.2022.61.s1.12
_version_ 1784802929844158464
author Hamzić, Jasmin
Raos, Dora
Radulović, Bojana
author_facet Hamzić, Jasmin
Raos, Dora
Radulović, Bojana
author_sort Hamzić, Jasmin
collection PubMed
description Calcium channel blockers and beta-blockers toxicity/poisoning are one of the most common causes of poisoning. More importantly, they are among the deadliest types of poisoning caused by cardiac drugs that emergency physicians can encounter. Common toxidrome caused by these medications includes the following symptoms: hypotension, bradycardia, hypoglycemia/hyperglycemia, hypothermia, arrhythmia, and seizures. Treatment is usually complex, It consists of administration of various medications, such as crystalloids, intravenous calcium, glucagon, vasopressors/inotropes, and especially high-dose insulin euglycemic therapy. In this paper, we will review the mechanism for this type of treatment, propose a potential protocol for its application and address possible adverse effects. High-dose insulin euglycemic therapy should be an integral part of the treatment protocol for calcium channel blockers and beta-blockers toxicity.
format Online
Article
Text
id pubmed-9536162
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
record_format MEDLINE/PubMed
spelling pubmed-95361622022-10-26 HIGH-DOSE INSULIN EUGLYCEMIC THERAPY Hamzić, Jasmin Raos, Dora Radulović, Bojana Acta Clin Croat Reviews Calcium channel blockers and beta-blockers toxicity/poisoning are one of the most common causes of poisoning. More importantly, they are among the deadliest types of poisoning caused by cardiac drugs that emergency physicians can encounter. Common toxidrome caused by these medications includes the following symptoms: hypotension, bradycardia, hypoglycemia/hyperglycemia, hypothermia, arrhythmia, and seizures. Treatment is usually complex, It consists of administration of various medications, such as crystalloids, intravenous calcium, glucagon, vasopressors/inotropes, and especially high-dose insulin euglycemic therapy. In this paper, we will review the mechanism for this type of treatment, propose a potential protocol for its application and address possible adverse effects. High-dose insulin euglycemic therapy should be an integral part of the treatment protocol for calcium channel blockers and beta-blockers toxicity. Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2022-06 /pmc/articles/PMC9536162/ /pubmed/36304811 http://dx.doi.org/10.20471/acc.2022.61.s1.12 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle Reviews
Hamzić, Jasmin
Raos, Dora
Radulović, Bojana
HIGH-DOSE INSULIN EUGLYCEMIC THERAPY
title HIGH-DOSE INSULIN EUGLYCEMIC THERAPY
title_full HIGH-DOSE INSULIN EUGLYCEMIC THERAPY
title_fullStr HIGH-DOSE INSULIN EUGLYCEMIC THERAPY
title_full_unstemmed HIGH-DOSE INSULIN EUGLYCEMIC THERAPY
title_short HIGH-DOSE INSULIN EUGLYCEMIC THERAPY
title_sort high-dose insulin euglycemic therapy
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536162/
https://www.ncbi.nlm.nih.gov/pubmed/36304811
http://dx.doi.org/10.20471/acc.2022.61.s1.12
work_keys_str_mv AT hamzicjasmin highdoseinsulineuglycemictherapy
AT raosdora highdoseinsulineuglycemictherapy
AT radulovicbojana highdoseinsulineuglycemictherapy